Walkie Talkie

How to talk about your condition, when to stop, and how to treat

By Dr. Julie Biermann, MD, MPH Associate Professor of Pediatrics, University of Illinois Medical School and Associate Director of the Center for the Study of Health in the Media and Media and Communications (CMSC) at the University of California, San Francisco and the Center on Health Media at the Johns Hopkins University School of Medicine.

This article originally appeared on The Conversation.

Subscribe to The Conversation on YouTube.

Dr. Bierman is the author of two bestselling books, The Conversation: How to Talk about your Condition, when not to stop and how not to treat and a co-author of The Conversation’s New Epidemic, co-authored by Dr. Biersmann, on which the article is based.

Dr Biermen is a coauthor of the New Epidemic and co-editor of the Journal of Health Media and Communication.

Her work focuses on the intersection of health and communication, and is an integral part of the CMSC, a leading provider of high-quality content for the health and health-related content communities.

Dr Jules Biermans, MD is the Chief Medical Officer and Director of Clinical Services at the Centers for Disease Control and Prevention (CDC).

He has served as Senior Vice President for Health Communications and is also the Chief Executive Officer of The Center for Health Media, which is an affiliate of the American Heart Association.

Drs Bier and Bier are currently working on the final version of the “Talking about your illness” article.

Dr Misha B. Gorman, MD (UCSF) is the founding director of the National Center for Advancing Translational Sciences (NATS) and the Chief Scientist at the NATS Center for Integrative Genomics and Cancer.

She is also a member of the Advisory Committee for the National Institutes of Health and a fellow of the Society for Neuroscience.

Dr Gorman is the former Chief Scientific Officer and Deputy Director of National Cancer Institute (NCI) from 1995-1999, and was a director from 1999-2010.

She was also the founding member of NCI’s Cancer Research Institute.

Dr Lila G. Novella, MD has served on the NCI Board of Directors since 2011.

She has also served on numerous committees, including the NCBI Scientific Advisory Board, the National Research Council Committee on Scientific Affairs, the Council of Scientific and Industrial Research, the Advisory Board for the Center of the Advancement of Medical Technology and the Advisory Council for Medical Research Institute of America.

Dr Novellas research interests include genetics, human genetics, the immune system, cancer, nutrition, cardiovascular disease, and obesity.

Dr Rachael S. Kudrick, MD and Dr Sarah L. Moseley, MD are researchers at the National Institute of Allergy and Infectious Diseases (NIAID).

Dr Kudricks interests include viral and bacterial infection and viral pandemic preparedness, virology, the impact of vaccines, immunization, vaccine-preventable diseases, infectious diseases, and vaccine safety.

Dr S Kudris is a professor of pediatrics at UCSF.

She earned her PhD in the School of Nursing at UCSB in 1994.

She served as a faculty member at UCSD from 1998 to 2000.

She spent 10 years at the U.S. Department of Health & Human Services.

Dr Kudrlis primary research interests are infectious disease epidemiology and pandemic immunization.

Dr Kudos are funded in part by grants from the National Science Foundation and the National Academy of Sciences.

Dr Moselys interests include influenza, respiratory viruses, infectious disease, pandemic vaccines, and the role of the media in pandemic media.